Document ID: chunk:federal_register_of_legislation:F2025L00150:front:0:p5
Version: federal_register_of_legislation:F2025L00150
Segment Type: other
Provision Reference: 
Character Range: 12677–15906

last dose of the drug was taken within the 7 days before clinical onset or clinical worsening;
Note: non-steroidal, anti-inflammatory drug is defined in the Schedule 1 - Dictionary.
 1.       having bilateral orchidectomy (orchiectomy) before clinical onset or clinical worsening;
 2.       taking one of the following anti-androgen medications for at least the 7 days before clinical onset or clinical worsening:
         1.           abiraterone;
         2.           androgen receptor blockers, including apalutamide, bicalutamide, darolutamide, enzalutamide, and cyproterone acetate; or
         3.           gonadotrophin releasing hormone agonists, including goserelin and leuprorelin;
 3.       an inability to sleep for an average of at least 5 hours daily for at least the 1 year before clinical onset or clinical worsening;
 4.       having infection with human immunodeficiency virus for at least the 5 years before the clinical onset or clinical worsening of myocardial infarction;
 5.       having gout at the time of clinical onset or clinical worsening of myocardial infarction;
 6.       undertaking physical activity of 6 METS or more within the 24 hours before the clinical onset or the clinical worsening of acute coronary syndrome (including myocardial infarction) or sudden death from ischaemic heart disease;
Note: MET (metabolic equivalent) is a unit of measure of the level of physical capability of the cardiorespiratory system. For example, 1 MET = cardiorespiratory effort associated with a person sitting, 3-4 METs = cardiorespiratory effort associated with a person walking at average walking pace (5 km/h) or light gardening.
 1.       experiencing a category 1A stressor within the 24 hours before the clinical onset or the clinical worsening of acute coronary syndrome (including myocardial infarction) or sudden death from ischaemic heart disease;
Note: category 1A stressor is defined in the Schedule 1 - Dictionary.
 1.       experiencing a category 1B stressor within the 24 hours before the clinical onset or the clinical worsening of acute coronary syndrome (including myocardial infarction) or sudden death from ischaemic heart disease;
Note: category 1B stressor is defined in the Schedule 1 - Dictionary.
 1.       experiencing an acute severe stressful event that causes a sudden, intense emotional or psychological response within the 12 hours before the clinical onset or the clinical worsening of acute coronary syndrome (including myocardial infarction) or sudden death from ischaemic heart disease;
 2.       experiencing the death of a family member or close friend within the 1 week before the clinical onset or the clinical worsening of acute coronary syndrome (including myocardial infarction) or sudden death from ischaemic heart disease;
 3.       using one of the following illicit drugs within the 24 hours before the clinical onset or the clinical worsening of acute coronary syndrome (including myocardial infarction) or sudden death from ischaemic heart disease:
         1.           amphetamines or amphetamine derivatives, including methamphetamine, 3, 4-methylenedioxymethamphetamine (Ecstasy or MDMA);
         2.           cocaine;
         3.           marijuana;